Workflow
Apple (AAPL) Should Be Up Again, Says Jim Cramer
Yahoo Finance· 2026-02-08 18:30
We recently published 12 Stocks on Jim Cramer’s Radar.  Apple Inc. (NASDAQ:AAPL) is one of the stocks on Jim Cramer's radar. Consumer electronics giant Apple Inc. (NASDAQ:AAPL)  is one of Jim Cramer’s favorite stocks. The CNBC TV host continues to hold the opinion that viewers and listeners should own the shares and not trade them. Investment bank Goldman Sachs discussed Apple Inc. (NASDAQ:AAPL) in January. It reiterated a Buy rating and a $330 share price target on the firm. The bank discussed the firm’s ...
Prediction: This Growth Stock Could Outperform the S&P 500 in 2026
The Motley Fool· 2026-02-08 18:30
The Trade Desk is trading at an unbelievable price tag.The ultimate goal for growth investors is to outperform the S&P 500. Otherwise, you're just wasting your time and should look for an index fund. Although I consider myself a growth investor, the reality is that it's all just different varieties of value investing. If you're a growth investor, you're buying a stock because you believe its business will rapidly grow and allow the stock to outperform your chosen index. At its core, that is value investing ...
Tapestry (TPR) Has Done Remarkable Things, Says Jim Cramer
Yahoo Finance· 2026-02-08 18:29
We recently published 12 Stocks on Jim Cramer’s Radar.  Tapestry, Inc. (NYSE:TPR) is one of the stocks on Jim Cramer's radar. Tapestry, Inc. (NYSE:TPR) is a luxury goods company. Its shares are up by 89% over the past year and by 17.8% year-to-date. UBS discussed the firm in late January as it raised the share price target to $125 from $123 and kept a Neutral rating on the shares. The bank outlined that Tapestry, Inc. (NYSE:TPR)’s upcoming second-quarter results would see the firm beat analyst forecasts f ...
Estee Lauder (EL) Doesn’t Have the Horses, Says Jim Cramer
Yahoo Finance· 2026-02-08 18:29
We recently published 12 Stocks on Jim Cramer’s Radar.  The Estée Lauder Companies Inc. (NYSE:EL) is one of the stocks on Jim Cramer's radar. The Estée Lauder Companies Inc. (NYSE:EL) is one of the largest cosmetics companies in the world. Its shares are up by 52% over the past year but are down by 6.8% year-to-date. Wells Fargo started the year on a strong note for the firm. It raised The Estée Lauder Companies Inc. (NYSE:EL)’s share price target to $111 from $95 and kept an Equal Weight rating on the sh ...
Qualcomm’s (QCOM) Hurt By Memory, Says Jim Cramer
Yahoo Finance· 2026-02-08 18:29
We recently published 12 Stocks on Jim Cramer’s Radar.  QUALCOMM Incorporated (NASDAQ:QCOM) is one of the stocks on Jim Cramer's radar. QUALCOMM Incorporated (NASDAQ:QCOM) is one of the largest semiconductor designers in the world. Its products are used in smartphones, cars, and other products. QUALCOMM Incorporated (NASDAQ:QCOM)’s shares are down by 18% over the past year and by 20% year-to-date. Cantor Fitzgerald discussed the firm ahead of its second-quarter earnings. It outlined that QUALCOMM Incorpor ...
NVIDIA (NVDA) Has All the Memory In the World, Says Jim Cramer
Yahoo Finance· 2026-02-08 18:29
We recently published 12 Stocks on Jim Cramer’s Radar.  NVIDIA Corporation (NASDAQ:NVDA) is one of the stocks on Jim Cramer's radar. AI GPU giant NVIDIA Corporation (NASDAQ:NVDA)’s shares are up by 42% over the past year and down by 1.8% year-to-date. Wolfe Research discussed the firm in early February. It reiterated an Outperform rating on NVIDIA Corporation (NASDAQ:NVDA)’s shares and commented that being patient was important when it came to the performance. Wolfe’s opinion mirrors Cramer, who has long ...
McKesson’s (MCK) More Powerful Than President Trump, Says Jim Cramer
Yahoo Finance· 2026-02-08 18:29
We recently published 12 Stocks on Jim Cramer’s Radar.  McKesson Corporation (NYSE:MCK) is one of the stocks on Jim Cramer's radar. McKesson Corporation (NYSE:MCK) is one of the largest healthcare services providers in America. Its shares are up by 59% over the past year and by 15% year-to-date. Several analysts have discussed McKesson Corporation (NYSE:MCK) in 2026. For instance, TD Cowen raised the share price target to $1,012 from $1,000 and kept a Buy rating on the shares in February. The coverage fol ...
TCPC SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds BlackRock TCP Investors of the Securities Class Action Lawsuit Deadline on April 6, 2026
TMX Newsfile· 2026-02-08 18:28
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages BlackRock TCP Investors Who Suffered Losses Exceeding $50,000 To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in BlackRock TCP between November 6, 2024 and January 23, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(New ...
BSV vs. SCHO: Short-Term Bond ETFs with Long-Lasting Dividend Potential
Yahoo Finance· 2026-02-08 18:27
Both the Schwab Short-Term U.S. Treasury ETF (NYSEMKT:SCHO) and Vanguard Short-Term Bond ETF (NYSEMKT:BSV) aim to provide low-cost, short-duration fixed-income exposure, appealing to investors seeking stability and modest income. This comparison looks at their fees, risk, makeup, and recent performance, helping highlight where their approaches to the short-term bond market differ. Snapshot (cost & size) Metric SCHO BSV Issuer Schwab Vanguard Expense ratio 0.03% 0.03% 1-yr return (a ...
MREO SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
TMX Newsfile· 2026-02-08 18:26
Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Mereo BioPharma Group plc for alleged violations of federal securities laws related to misleading statements about its clinical programs [4]. Group 1: Legal Investigation - The law firm is encouraging Mereo investors who suffered losses exceeding $50,000 to contact them for discussing legal options [1]. - A federal securities class action has been filed against Mereo, with a deadline of April 6, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that Mereo and its executives made false statements and failed to disclose the true state of the Phase 3 ORBIT and COSMIC programs, which did not meet their primary endpoints [4]. Group 2: Firm Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [3]. - The firm has offices in New York, Pennsylvania, California, and Georgia, indicating a broad operational reach [3]. Group 3: Whistleblower Encouragement - The firm is also seeking information from whistleblowers, former employees, shareholders, and others regarding Mereo BioPharma's conduct [6].